Company news

Liquidia Corporation news in 2025

Liquidia Corporation's news releases, calls and decks from 2025, newest first.

View company

Liquidia Corporation Reports Third Quarter 2025 Financial Results and Provides Corporate Update

November 2, 2025

Liquidia Corporation to Present at Upcoming Healthcare Investment Conferences

November 2, 2025

Liquidia Corporation to Report Third Quarter 2025 Financial Results on November 3, 2025

October 26, 2025

Liquidia Corporation to Host R&D Day in New York City on October 28, 2025

October 6, 2025

Liquidia to Present Clinical Data from ASCENT Trial at the CHEST 2025 Annual Meeting

September 28, 2025

Liquidia Announces Poster Presentations at the Pulmonary Hypertension Professional Association (PHPN) Symposium

September 10, 2025

Liquidia Corporation to Present at the 2025 Wells Fargo Healthcare Conference

August 26, 2025

Liquidia Corporation Reports Second Quarter 2025 Financial Results and Provides Corporate Update

August 11, 2025

Liquidia Corporation to Report Second Quarter 2025 Financial Results on August 12, 2025

August 4, 2025

Liquidia Receives $50 Million from Healthcare Royalty (HCRx) Following First Commercial Sale of YUTREPIA™

June 22, 2025

Liquidia Schedules First Commercial Shipment of YUTREPIA™ (treprostinil) Inhalation Powder for Patients with PAH and PH-ILD

June 1, 2025

Liquidia Corporation to Present at the 2025 Jefferies Global Healthcare Conference

May 27, 2025

U.S. FDA Approves Liquidia’s YUTREPIA™ (treprostinil) Inhalation Powder for Patients with Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)

May 22, 2025

Liquidia Corporation Provides Update on Litigation Filed by United Therapeutics

May 11, 2025

Liquidia Corporation Reports First Quarter 2025 Financial Results and Provides Corporate Update

May 7, 2025

Liquidia Corporation to Present at BofA Securities 2025 Health Care Conference

May 5, 2025

District Court Dismisses Dispute Filed by United Therapeutics Against Liquidia

May 1, 2025

Liquidia Corporation to Report First Quarter 2025 Financial Results on May 8, 2025

April 30, 2025

UPDATE – Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference

April 1, 2025

Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference

March 31, 2025

Liquidia Corporation Announces FDA Acceptance of New Drug Application Resubmission for YUTREPIA™ (treprostinil) Inhalation Powder

March 27, 2025

Liquidia Announces Poster Presentations at the American Thoracic Society (ATS) 2025 International Conference

March 26, 2025

Liquidia Corporation Reports Full Year 2024 Financial Results and Provides Corporate Update

March 18, 2025

Liquidia Corporation Strengthens Financial Position by Amending HealthCare Royalty Agreement to Incrementally Add Up to $100 Million

March 17, 2025

Liquidia Corporation to Report Full Year 2024 Financial Results on March 19, 2025

March 11, 2025

Liquidia Corporation to Present at 43rd Annual J.P. Morgan Healthcare Conference

January 7, 2025

Calls in 2025

Decks in 2025